Emerging data indicates that retatrutide, a innovative medication, may represent a significant advance in weight management. This therapy combines the effects of a GLP-1 analog and a GIP agonist , possibly offering a more outcome than current approaches . Patient research have revealed encouraging findings , including significant declines in weigh